During the past decade, Constantinou, Costas L MD (UIA Investigator) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 48 clinical trials were completed, i.e. on average, 960% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 20 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Constantinou, Costas L MD (UIA Investigator)" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Constantinou, Costas L MD (UIA Investigator)" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Constantinou, Costas L MD (UIA Investigator)" are "Adult Giant Cell Glioblastoma" (4 trials), "Adult Glioblastoma" (4 trials), "Adult Gliosarcoma" (4 trials), "Breast Adenocarcinoma" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Constantinou, Costas L MD (UIA Investigator)" in a lesser frequency.

Most popular intervention types in "Constantinou, Costas L MD (UIA Investigator)" are "Drug" (58 trials), "Other" (40 trials), "Biological" (26 trials), "Radiation" (8 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Bevacizumab" (15 trials), "Quality-of-Life Assessment" (12 trials), "Carboplatin" (9 trials) and "Paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Constantinou, Costas L MD (UIA Investigator)" are 52 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Constantinou, Costas L MD (UIA Investigator)". undefined are not yet recruiting, 1 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Constantinou, Costas L MD (UIA Investigator), undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Constantinou, Costas L MD (UIA Investigator), 5 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Constantinou, Costas L MD (UIA Investigator) has several departments that took part in Clinical trials: "Peoria Pulmonary Associates, LTD" - 4 trials